Product
Patsnap Eureka
For R&D, Patsnap Eureka makes reading and utilizing patents & technical documents easy.
Patsnap Eureka AIR
Designed for self-driven R&D workflows. Generate viable solutions, solve complex R&D challenges, empower your innovation with AI.
Patsnap Eureka Materials
Designed for material experts only. Revolutionize your material R&D, from search, analyze, to developing new materials.
Feature
TechResearch
Generate reliable direction feasibility study reports for your R&D in just a few steps.
TechSeek
Discover and master advanced knowledge NOW. Basics, ideas, possibilities, all at once.
TechMind
As an expert in R&D Theories, TechMind can generates customized viable solutions instantly.
TechRisk
Analyze your overall solution with one click, know your potential R&D risks in advance.
TechMonitor
Get weekly tech updates, stay abreast of the latest tech innovations and key insights.
Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
140 results about "Coagulation function" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
Coagulation is the biological process by which blood hardens into solid form. There are two related and critical functions of coagulation. First, it seals any breach of a human body’s primary organ of protection against harmful, external agents such as germs — the skin.
Device and method for detecting the coagulation functions of global, especially primary hemostasis
InactiveUS7223365B2Low cost of measurementSimple and low-maintenance techniqueUltrasonic/sonic/infrasonic diagnosticsInfrasonic diagnosticsBlood plasmaPlasma rich platelet
A method and a device are provided for examining the properties of the global, in particular the primary, hemostasis functions in whole blood or platelet-rich plasma. A volumetric blood flow is preferably adjusted, depending on the measured pressure of the volumetric flow, so that the shear rate or the shear force, whose action in the reaction opening causes blood components, in particular thrombocytes, to deposit, follows a predetermined characteristic curve and in particular is held constant.
Owner:FREIHERR VON DER GOLTZ VOLKER
Freeze-dried platelets as a diagnostic agent
Owner:CELLPHIRE INC
Methods for Treating Bleeding Disorders
Owner:BAXALTA GMBH
Blood perfusion device having anti-coagulation function and controlled-release function and manufacturing method thereof
ActiveCN104147653AFacilitated releaseRealize integrationOther blood circulation devicesAntithrombogenic treatmentAnti coagulationBiochemistry
The invention discloses a blood perfusion device having the anti-coagulation function and the controlled-release function and a manufacturing method of the blood perfusion device. The blood perfusion device comprises a perfusion device body provided with an adsorption chamber. The adsorption chamber contains an adsorbent and anti-coagulation and controlled-release gel having the thermosensitive characteristic. The anti-coagulation and controlled-release gel contains anti-coagulation matter. The anti-coagulation and controlled-release gel can be formed by dissolving the anti-coagulation matter, a compound with the two ends containing double bonds and a N-alkyl acrylamide type monomer having the thermosensitive characteristic in water through polymerization. By the adoption of the blood perfusion device having the anti-coagulation function and the controlled-release function, the anti-coagulation function is integrated with the blood purification function, the convenience of clinical blood perfusion is improved, and the risk of introducing pyrogen additionally is avoided; the thermosensitive characteristic and the mechanical property of the anti-coagulation and controlled-release gel can be adjusted by changing reactant components, the crosslinking density, the ion strength and the water content; when coagulation happens, coagulated blood clots can squeeze the anti-coagulation and controlled-release gel, so that release of the anti-coagulation matter can be instantly accelerated by the anti-coagulation and controlled-release gel, and the effect of effectively preventing the coagulation range from expanding is achieved.
Owner:JAFRON BIOMEDICAL
Terpenoid and preparation method and application thereof
ActiveCN103553919AAvoid smallImprove coagulation functionCarboxylic acid esters separation/purificationEster active ingredientsCoagulation functionEnzyme
The invention provides a terpenoid shown by the formula I or pharmaceutically acceptable salt, ester or hydrate thereof. The invention also provides a preparation and application of the terpenoid. In the invention, a carbon-drop diterpene new compound separated from leonurus is carbon-drop labdane diterpene obtained from the nature for the first time. The compound can obviously shorten the PT (prothrombin time), APTT (activated partial thromboplastin time) and TT (thrombin time) in vitro and obviously increase the amount of FIB (fibrinogen) in blood, and realizes a certain effect on enhancing the coagulation function, thereby providing a new option for developing a novel natural coagulation drug.
Owner:CHENGDU FIRST PHARMACEDTICAL CO LTD
Wet type electric dust collector with pre-coagulation function
InactiveCN105817325AImprove dust and fog removal efficiencyReduce escape rateExternal electric electrostatic seperatorElectrode constructionsPhase changeTower
The invention provides a wet electric precipitator with pre-coagulation function aiming at the deficiency that the existing wet electric precipitator has low dedusting efficiency for superfine dust particles. The wet electrostatic precipitator is arranged on the top of the desulfurization absorption tower, and mainly includes a wet electrostatic precipitator and a condensing heat exchanger. The wet electrostatic precipitator is arranged above the condensing heat exchanger. Composed of cathode suspension and anode assembly, the condensing heat exchanger is installed between the outlet of the absorption tower mist eliminator and the wet electrostatic precipitator, and the wet electrostatic precipitator and the condensing heat exchanger are respectively equipped with flushing devices. The flue gas to be treated passes through the desulfurization absorption tower, the outlet flue of the absorption tower, the phase change condensation flow equalization chamber, the wet electrostatic precipitator and the outlet flue of the dust collector in sequence from bottom to top, and then is discharged from the chimney.
Owner:JIANGSU FUDING ENERGY SCI & TECH
Preparation method and application of water treatment agent
InactiveCN106902743AWith coagulation functionDoes not affect the adsorption effectOther chemical processesWater contaminantsSludgeCoagulation function
The invention relates to the technical field of water treatment. In order to solve the problems that an adsorbent is expensive, and the sludge quantity is doubly increased and the sludge treatment cost is increased after excessive adsorbents are added, the invention provides a preparation method and application of a water treatment agent. The preparation method comprises the following steps: performing organic modification on powder and an organic modifier by a modifying machine to obtain organic modified powder; adding an inorganic modifier and an organic modifier sequentially or simultaneously, stirring, adding the organic modified powder, or adding an inorganic modifier and an organic modifier sequentially or simultaneously, stirring, adding the organic modified powder and stirring to obtain the water treatment agent. Adsorption and coagulation functions are unified, the use efficiency of the water treatment agent is greatly improved, the cost is reduced, and the equipment management difficulty is reduced.
Owner:常涛
Polyphosphonic acid type water reducing agents and synthesis method thereof
The invention discloses polyphosphonic acid type water reducing agents. The polyphosphonic acid type water reducing agents are prepared from raw materials as follows: a, methyl allyl polyethenoxy ether; b, acrylic acid or methylacrylic acid; c, vinylphosphonic acid; d, ammonium persulfate; e, mercaptoacetic acid or mercaptopropionic acid; f, trisodium phosphate. The mole ratio of a to b to c to f is 1:(3-4):(0.2-1):(2-3); the material d accounts for 0.2%-0.5% of the total weight of all the materials; the material e accounts for 0.1%-0.3% of the total weight of all the materials. Besides, the invention further discloses a synthesis method of the polyphosphonic acid type water reducing agents. Compared with common polycarboxylate superplasticizers, the phosphonic acid and carboxylic acid copolymerized water reducing agent has a better water reducing effect and a slump keeping effect and has a certain delayed coagulation function on concrete.
Owner:吉林众鑫化工集团有限公司
High-activity blood coagulation factor XI mutant and preparation and application of gene therapy/editing vector and recombinant/fusion protein thereof
ActiveCN108220274AImprove coagulation functionGood prospects for alternative treatmentsPeptide/protein ingredientsNucleic acid vectorMutantOrganism
Owner:RUIJIN HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIV SCHOOL OF MEDICINE +3
Hemostasis needle and preparing method and application thereof
ActiveCN109330654AEffectively blockedEffective synchronous hemostasisSurgical needlesOcculdersCross-linkDrug administration
The invention belongs to the field of biomedical polymer materials, and particularly relates to a hemostasis needle and a preparing method and application thereof. The hemostasis needle comprises a syringe needle and a hemostasis coating for coating the surface of the periphery of the syringe needle, wherein the hemostasis coating is a non-toxic cross-linked polymer which can swell and shed off from the surface of the periphery of the syringe needle when meeting a solvent. The hemostasis needle prepared by means of the method is utilized for puncturing the blood vessels and the visceral organs, after the hemostasis needle is pulled out, the coating is left at the puncturing position to block a puncturing hole, and thus synchronous hemostasis is achieved. The preparing method of the hemostasis needle is easy to operate and low in cost, takes effect quickly, and can be widely applied to the fields such as drug administration, blood sampling, sampling and interventional therapy on patients with normal or abnormal clinical blood coagulation functions. The hemostasis needle is adjustable in size, easy to produce on a large scale, capable of effectively solving the problem that unnecessary hemorrhage is caused when the patients with normal or abnormal clinical blood coagulation functions are subjected to blood vessel and visceral organ puncturing, and free of obvious untoward effects.
Owner:HUAZHONG UNIV OF SCI & TECH
Production process of French type crispy cakes
The invention provides a production process of French type crispy cakes. The French type crispy cakes are prepared according to the steps as follows: a mixture of grease, white granulated sugar, salt and water is heated to 90-110 DEG C; then wheat flour is added into the mixture, and the mixture and the wheat flour are mixed fully to the temperature of 45-65 DEG C; an egg liquid is added for three times, and then stirring is performed until a paste is smooth, and the blank temperature is 40-60 DEG C; the stirred paste is poured into a crispy cake extruder and extruded into strips; the strips are baked at the tunnel oven temperature of 170-260 DEG C for 17-30 min; and baked semi-finished products are cut into strips, and the strips and a syrup are mixed, stirred and transmitted to a forming machine for cutting and forming. According to the production process of the French type crispy cakes, a braking processing technology and a physical mixing manner are adopted, no artificial addition colors and preservatives are caused, the egg content reaches up to 30%-40%, the nutritional values of products are increased, the golden luster is increased, a coagulation function is realized, and eggs are used as swelling agents, so that sizes of the products are increased, and the products are sweet and mellow in custard, crispy and agreeably sweet in taste; and added wheat flour cannot produce a burning smell, and the overall taste of the French type crispy cakes is improved.
Owner:NANJING HONGSENLIN FOOD
Antegrade aorta infusion tube having internal blocking function, application and usage method
InactiveCN106178164AProtective functionClean fieldOther blood circulation devicesExtracorporeal circulationAortic dissection
The invention discloses an antegrade aorta infusion tube having an internal blocking function, application and a usage method. The antegrade aorta infusion tube comprises a blocking balloon, a liquid injecting catheter and an infusion tube body, wherein the infusion tube body penetrates through the blocking balloon and is in sealed and fixed connection with the blocking balloon, the liquid injecting catheter is in sealed and fixed connection with the blocking balloon, and one end of the liquid injecting catheter is communicated with the blocking balloon. In a Sun's procedure for treating a Stanford type-A aortic dissection, on one hand, blood circulation in the descending aorta is blocked through an infusion balloon to obtain a clean operating field; on the other side, blood infusion is conducted on the lower half body by combining the liquid injecting catheter with an extracorporeal circulation device while the descending aorta is blocked. Therefore, the body temperature of a patient is not needed to be reduced to be too low, and accordingly the internal organ functions and coagulation functions of the patient are well protected. The antegrade aorta infusion tube further simplifies an operating method, improves the operating safety and improves the overall treating effect.
Owner:崔勇
Composite type intraoperative stent system and using method thereof
ActiveCN106388972AReduce the effects of coagulationShorten operation timeStentsBlood vesselsAv graftLinear control
The invention provides a composite type intraoperative stent system which comprises an artificial vessel capable of being anastomosed, a linear control released left subclavian artery covered stent vessel and a balloon-expandable type descending aorta covered stent artificial vessel; the artificial vessel is connected with the balloon-expandable type descending aorta covered stent artificial vessel; the left subclavian artery covered stent vessel is arranged at the connecting part of the artificial vessel and the balloon-expandable type descending aorta covered stent artificial vessel and communicates with the artificial vessel and the balloon-expandable type descending aorta covered stent artificial vessel; and the balloon-expandable type descending aorta covered stent artificial vessel is internally provided with a balloon. The composite type intraoperative stent system can shorten the operation time, reduces influence of deep hypothermic circulatory arrest on the coagulation function of a patient, lowers the difficulties of vascular anatomy and anastomosis and increase the success rate of an operation.
Owner:FUJIAN PROVINCIAL HOSPITAL
Mucous membrane stripperused under the assistance of endoscope
ActiveCN107693110AImprove the efficiency of cutting and strippingShorten operation timeMedical devicesSurgical instruments for heatingElectricityBlood coagulations
The invention relates to amucous membrane stripper used under the assistance of an endoscope. The mucous membrane stripper comprises a cutter head, a transmission wire, a fixed handle, a rotary handlefor driving the rotation of the transmission wire, and an electric coupling device for connection with high frequency electricity. The front end of the transmission wire protrudes from the fixed handle to be connected with the cutter head, the rotary handle is arranged on the fixed handle, the rotary handle is connected with the transmission wire through a vertical transmission structure. The injection wire and the cutter head are provided with injection channels inside, the injection channel of the transmission wire is communicated with the injection channel of the cutter head, and the rearend of the transmission wire protrudes from the rear end of the fixed handle to be connected with an injection interface. The cutter head of the mucous membrane stripper can be rotated at a high speedso asto improve the efficiency of incision and stripping; under the assistance of an endoscope, the mucous membrane stripper can cut and strip mucous membranes, perform submucous injection without replacing the instrument, shorten the operation time, and save the operation cost; when the mucous membrane stripper is connected with a high frequency electricity, the mucous membrane stripper can alsoswitch to the coagulation function for blood coagulation and hemostasis.
Owner:WEST CHINA HOSPITAL SICHUAN UNIV
Rapid detection method for detecting whole blood coagulation function
InactiveCN102478580AReduce barrierAnalysing fluids using sonic/ultrasonic/infrasonic wavesBiological testingWhole blood unitsAnti coagulation
A rapid detection method for detecting a whole blood coagulation function detects the coagulation function of blood by means of ultrasonically detecting conditions of rotation (movement) of a metal bar in a whole blood specimen. In the method, plasma is not required to be separated, whole blood is directly sampled in a detecting cup (anti-coagulation or coagulation), a metal-bar-shaped stirrer (capable of being wrapped by other materials) is arranged in the detecting cup, and during detection, a rotating magnet is additionally mounted at the bottom of the detecting cup. Before the blood is coagulated, the stirrer rotates along with the rotating magnet, and after the blood is coagulated, the stirrer stops rotating due to resistance. An ultrasonic detector is additionally mounted on a side surface of the detecting cup, and a blood coagulation condition is judged by means of detecting rotation / fixation of the stirrer in the blood.
Owner:SINNOWA MEDICAL SCI & TECH
Inactivating system for circulating tumor cells in blood and application thereof
PendingCN107308515AKeep aliveSolve the problem of blood spreadOther blood circulation devicesMedical devicesWhole blood productApoptosis
The invention discloses a photochemical inactivating system for circulating tumor cells and / or tumor stem cells in blood or blood products and application of riboflavin in preparation of an agent for inactivating the circulating tumor cells and / or the tumor stem cells in the blood or the blood products in a photochemical way. According to the system and application, the circulating tumor cells and / or the tumor stem cells in the peripheral blood are completely induced to be subjected to apoptosis to lose the proliferation ability, so that blood cells, coagulation function and immune function of a patient are maintained to the utmost extent.
Owner:GENERAL HOSPITAL OF PLA
Functional guidance muscle tissue repair membrane and preparation method and application thereof
ActiveCN110404117AGood biocompatibilityImprove mechanical propertiesProsthesisMuscle tissueMicron scale
The invention discloses a functional guidance muscle tissue repair membrane and a preparation method and application thereof. The functional guidance muscle tissue repair membrane comprises an irregularly arrayed micron-scale fiber membrane which is prepared through electrostatic spinning and by taking polycaprolactone and collagen as base materials, wherein the fiber diameter of the irregularly arrayed micron-scale fiber membrane is 1-10 [mu]m, and the membrane thickness of the irregularly arrayed micron-scale fiber membrane is 50-500 [mu]m; and the functional guidance muscle tissue repair membrane can further comprise a protein hydrogel loaded on the repair membrane and having a coagulation function, and a protein bound on the hydrogel and promoting growth of cells. The functional guidance muscle tissue repair membrane has excellent biocompatibility and mechanical properties, and can effectively promote regeneration and repair of muscle tissue, and the preparation method of the functional guidance muscle tissue repair membrane is scientific and simple, the technological process is controllable, and the functional guidance muscle tissue repair membrane is widely applied to preparation of drugs for promoting regeneration and repair of the muscle tissue.
Owner:THE NAT CENT FOR NANOSCI & TECH NCNST OF CHINA
Product for treating hemophilia A and application thereof
The invention discloses a product for treating hemophilia A and an application thereof. The product comprises an expression cassette of a BDD FVIII gene, a recombinant vector containing the expressioncassette, a recombinant virus, especially a recombinant lentivirus, a recombinant bacterium or a recombinant cell. A promoter of the BDD FVIII gene in the expression cassette comprises a PF4 promoter. According to the lentiviral vector containing the PF4 promoter and the BDD FVIII gene expression cassette, the BDD FVIII gene can be specifically expressed in platelets formed by cytoplasm sheddingof megakaryocytes derived from CD34+ cells through the PF4 promoter, so that the blood coagulation function is achieved, and the lentiviral vector can be applied to gene therapy of hemophilia A of allages.
Owner:济南赛尔生物科技股份有限公司
Novel method for detecting and evaluating blood coagulation function
The invention disclose a method for detecting and evaluating blood coagulation function by directly detecting change of erythrocyte and platelet quantity by whole blood after and before a reagent for inducting blood to coagulate is added. The method not only can comprehensively reflect a total blood coagulation function level of a blood sample, but also can respectively directly reflect participation of platelet and erythrocyte in a blood coagulation process and the coagulation function of various blood cells, and can comprehensively reflect blood solidification capability. The method, combining different blood coagulation reagent, by change of the platelet and erythrocyte quantity, reflect a blood coagulation path function in the blood sample, and the function of various blood coagulation factors in the blood.
Owner:江苏英诺华医疗电子科技有限公司
Recombinant blood coagulation factor VIII and application thereof
ActiveCN113248594AReduced responseEfficient coagulation functionFactor VIIVectorsBlood coagulation factor VIIITherapeutic effect
The invention relates to a recombinant blood coagulation factor VIII and application thereof. The B domain of the recombinant blood coagulation factor VIII comprises more than 80% of an amino acid sequence as shown in SEQ ID NO: 1 or SEQ ID NO: 2. The B domain of the recombinant blood coagulation factor VIII is subjected to gene modification, and is rich in glycosylation sites, so that the recombinant blood coagulation factor VIII has an efficient blood coagulation function, is easy to secrete outside cells, is easy to interact with auxiliary factors such as thrombin (FIIa) and the like, is low in antibody reaction, and can effectively guarantee the treatment effect, reduce the immunological rejection risk and save the treatment cost.
Owner:BEIJING MEIKANG JIMIAN BIOTECH CO LTD
Sample cup for detecting coagulation function and application thereof
PendingCN107843525ALow costImprove accuracyFlow propertiesBiological testingMedicineCoagulation function
The invention provides a sample cup for detecting a coagulation function and application thereof, which relate to the technical field of medical apparatus and instruments. The sample cup comprises a cup body and a cup cover, wherein a stirring device is arranged in the cup body; an activating agent is arranged in the cup body; the cup cover is provided with a through hole for a probe to insert. After being added with a blood sample to be detected, the sample cup can be directly placed into a coagulation detector so as to be detected, so that pretreatment is not needed, the speed is fast, the efficiency is high, the pollution is avoided, and the accuracy is high. The application of the sample cup in detecting the coagulation function is wide, and the technical problem that a fast, safe, convenient and effective product for detecting the coagulation function is in shortage in the prior art is solved.
Owner:世纪亿康(天津)医疗科技发展有限公司
Blood coagulation function index detection test paper and preparation and signal processing method thereof
ActiveCN112748171AQuick testImplement testMaterial analysis by electric/magnetic meansPhotovoltaic energy generationEngineeringBlood coagulations
The invention discloses blood coagulation function index detection test paper and a preparation and signal processing method thereof. The blood coagulation function index detection test paper comprises a substrate layer, a middle interlayer and a hydrophilic layer, wherein the middle interlayer is adhered between the substrate layer and the hydrophilic layer, the substrate layer is provided with an organic electrochemical transistor containing a reaction film for detecting blood coagulation function indexes, and the middle interlayer is provided with a sample introduction channel to the organic electrochemical transistor reaction region. The current change trend of the organic electrochemical transistor is used for reflecting blood coagulation states in different stages, and the current change time inflection point is determined by detecting the current change in different blood coagulation states, so that the detection of blood coagulation function indexes is realized. The invention further provides a signal processing method for improving the precision and accuracy of the test paper for measuring a blood coagulation function index, and reducing the difference of the performance of the test paper, which is influenced by the instability of the production process.
Owner:HUNAN UNIV OF TECH
Oligopeptide containing Hyp-Gly sequence and having antiplatelet and antithrombotic functions
ActiveCN111647043ASmall side effectsOvercoming bleeding problemsTetrapeptide ingredientsTripeptide ingredientsBleeding timeThrombus
The invention discloses an oligopeptide containing an Hyp-Gly sequence and having antiplatelet and antithrombotic functions. The invention provides the oligopeptide containing the Hyp-Gly sequence orsalt forms thereof. The oligopeptide containing an OG sequence can be prepared through artificial synthesis as well as enzymolysis of fish skin. The molecular weight of the oligopeptide containing theOG sequence is smaller than 1,000 Da, the mass ratio of the oligopeptide to total enzyme-digested products is 65%-95%, and the oligopeptide has a specific inhibition effect on ADP-induced platelet aggregation, can inhibit thrombosis, does not affect the blood coagulation function, does not prolong the bleeding time and is very small in bleeding risk; and the oligopeptide has the characteristics of resistance to gastrointestinal tract digestive enzyme enzymolysis and easiness in absorption.
Owner:CHINA AGRI UNIV
Directionally driven targeted hemostasis micromotor and preparation method thereof
InactiveCN112891613AAchieve targeted deliveryRealize three-dimensional space therapySurgical adhesivesPharmaceutical delivery mechanismEngineeringBovine serum albumin
The invention provides a directionally driven targeted hemostasis micromotor, which is characterized in that microporous starch is used as a carrier for delivering a hemostasis drug, nano Fe3O4 is self-assembled on the surface of the microporous starch to serve as a power system, and the hemostasis drug (thrombin) is loaded on the surface of the microporous starch / nano Fe3O4 by using bovine serum albumin. The thrombin on the micromotor can stably exist on the carrier, and under the stimulation of a magnetic field, the effect of centralized and directional delivery is achieved, so that the blood coagulation function of the thrombin is fully played; and meanwhile, under the stimulation of an external magnetic field, the micromotor can generate power to move towards a target position, and when the position of the magnetic field is changed, the movement direction of the micro motor can be changed, so that the micromotor is suitable for various types of wound surfaces and wounds.
Owner:SOUTHWEST UNIVERSITY
Efficient cement grinding aid
The invention relates to the technical field of cement additives, in particular to an efficient cement grinding aid which is prepared from the following raw materials in weight percentage: 10-15% of triethanolamine, 10-20% of propylene glycol, 10-15% of butanediol, 5-15% of hexanediol, 5-10% of water holding cellulose, 1-2% of graphite, 0.02-0.06% of sodium dodecyl benzene sulfonate and the balance of water. The efficient cement grinding aid is applicable to the field of cement grinding assistance. When cement is ground and the efficient cement grinding aid is added, the cement grinding efficiency can be greatly improved, and the cement strength can be improved; the efficient cement grinding aid has certain delayed coagulation function, and triethanolamine is replaced by part of alcohol, so that the cost is reduced.
Owner:天瑞集团南召水泥有限公司
Liver disease examination device with blood coagulation function
InactiveCN108743174AIncrease the speed of solidificationWill not interfereOperating tablesPediatricsBlood coagulations
The invention discloses a liver disease examination device with a blood coagulation function. The liver disease examination device comprises a bed board, wherein four supporting legs are fixedly connected to the lower side of the bed board; a groove with a downward opening is formed at the lower side of the bed board; a moving block is arranged in the groove; a horizontally arranged threaded through hole is formed in the moving block; a threaded rod is connected in the threaded through hole through threads, and is erected on both side walls of the groove; a disinfection device is fixedly connected to the lower side of the moving block through a connecting block; and the upper side of the bed plate is provided with a sliding groove with an upward opening, and a sliding block is arranged inthe sliding groove. The liver disease examination device provided by the invention has the beneficial effects that in order to accelerate the blood coagulation speed, a heating resistance wire is energized, heat is generated after the heating resistance wire is energized, then a fan is started, the generated heat is blown into a cavity by the fan, and a pricking pin is placed below two air outlets, so that the heat ejected from the two air outlets is concentrated to one place, thus effectively accelerating the blood coagulation speed.
Owner:RIZHAO HOSPITAL OF TCM
Method for coagulation related function detection by EDTA (ethylene diamine tetraacetic acid) anticoagulation
The invention is a method for coagulation related function detection by EDTA (ethylene diamine tetraacetic acid) anticoagulation, and belongs to the field of medical in vitro diagnosis industry. According to the method, the EDTA anticoagulation can be used for blood cell count by a blood analyser, and can be used for detection of platelet aggregation and other blood coagulation functions.
Owner:SINNOWA MEDICAL SCI & TECH
Blood coagulation functional system detection apparatus
InactiveCN1595106AMeet the clinical diagnosisAdd test functionMaterial analysis by optical meansConstant powerBlood coagulations
This invention discloses a cruor function system detection apparatus. The pressure constant power is separately connected with control computer, four-path light source, preheat and constant heat controller, data storage and copy machine. The four-path light source is separately connected with pressure constant power, royal purple light switch motor, royal purple light switch, four-path specimen test bench and four-path light sources. The four-path specimen test bench is separately connected with preheat and constant heat controller, specimen mixture motor signal amplifier and controller and royal purple filter switch apparatus. The control computer is separately connected with data storage and copy machine and constant pressure power, signal amplifier and controller.
Owner:武汉市华中电测技术开发有限公司
Bowel-relaxing and toxin-expulsing prescription
InactiveCN105362925AImprove hemodynamic indicatorsImprove clinical symptomsDigestive systemPlant ingredientsPortal venous systemPhyllanthus urinaria
Owner:李凯杰
Method for cooperatively controlling multiple pollutants of flue gas by using charge adsorbent strengthened electric bag device
ActiveCN102671506BLarge structure sizeLess investmentCombination devicesAuxillary pretreatmentElectricityFlue gas
The invention relates to a method for cooperatively controlling multiple pollutants of a flue gas by using a charge adsorbent strengthened electric bag device. The method comprises the steps of: pre-charging (positive charges) a mercury-removing adsorbent through an outer charge spray gun and spraying the mercury-removing adsorbent to an electric bag combined region of the electric bag compound device through an insulating conveying pipe; capturing and collecting fine particles, heavy metals (mercury and the like), congealable substances (SO3 and the like) and the like to the adsorbent to form big particles which are good for a filtering bag to capture and collect by utilizing Coulomb coagulation function caused by mutual attraction between adsorbent particles with positive charges and fine particles which are charged with negative charges while passing an electric region, but are not captured and collected; and finally, capturing and collecting the coagulated big particles by utilizing a bag-type dust collector to realize the purpose of cooperatively removing fine particles, heavy metals and congealable substance in the flue gas. Compared with the prior art, the method for cooperatively controlling multiple pollutants of the flue gas by using the charge adsorbent strengthened electric bag device, disclosed by the invention, has the advantages of high efficiency, low cost and the like.
Owner:SHANGHAI JIAO TONG UNIV
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com